Industry-funded trials of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, reported improved heart failure outcomes in patients with
The ability to leverage real-time data would be a powerful tool in helping clinicians decide the next steps for ICU patients.
Weight loss drug coverage, the MAHA movement, Medicaid, Medicare, trans health, medical debt, miscarriage care, and more.
A 50-year-old man presented with a 1-year history of progressive headaches. On examination, there was neck stiffness and dysmetria in both arms. An MRI of…
In this episode, we’re joined by Dr. Piraye Yurttas Beim, founder and CEO of Celmatix, a women’s health biotech company. She discusses the funding the…
Stanford Medicine scientists are studying why even brief trips into space can weaken muscle and heart tissue, mimicking decades of aging on Earth.
Joining Matthew Holt (@boltyboy) on #THCBGang on Tuesday November 26 at 1PM PT 4PM ET are THCB regular writer and ponderer of odd juxtapositions Kim…
You’ve probably heard of the placebo effect. But there’s another side to that coin. It’s the nocebo effect. And it can harm your well-being. Here’s…
The White House has cut Intel’s CHIPS Act award by over $600 million. Initially set to receive $8.5 billion, the company will now get up…
With climate change, exposure to floods has increased and is linked to adverse health outcomes, such as injuries, diseases, and mental health harms, all of…
U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk’s Wegovy, for more than 7 million people with Medicare and…
